Medications for acromegaly are typically indicated for patients that are not surgical candidates or do not wish to have surgery, following subtotal tumor resection, and for patients with persistent elevations in GH and IGF-1 levels that are awaiting the effectiveness of radiation-based treatments. This evidence concerns the gene GH1 and acromegaly.